AGE's logo.
Ticker Symbol: AGE

AgeX Therapeutics Inc

$0.79 - 14-07-2024 4 p.m. ET

Exchange: NYSE MKT LLC Country: US Currency: USD Asset Type: Common Stock CIK:0001708599

Company Profile

agex therapeutics, inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the united states. the company's lead cell-based therapeutic candidates in development include agex-bat1, a cell therapy product candidate for the treatment of various age-related metabolic disorders, such as type ii adult-onset diabetes; and agex-vasc1, a cell-based therapy to restore vascular support in aged ischemic tissues, such as the ischemic heart. its lead drug-based therapeutic candidate in discovery is agex-itr1547, a drug-based formulation to restore regenerative potential in a range of aged tissues afflicted with degenerative diseases. in addition, the company markets human embryonic stem cells; and genecards database suite, including genomic interpretation algorithms and analysis tools for use by researchers at pharmaceutical and biotechnology companies, and other institutions. agex therapeutics, inc. ha

Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Standard Industrial Classification Code (SIC code): 2834
Address: 965 Atlantic Ave Ste 101
CEO: Michael West
  • Health Technology
  • Pharmaceuticals: Major


Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $0.65
Change: $0.00 ( -0.31%)
Days Range: $0.65 - $0.69
Beta: -0.36
52wk. High: $1.00
52wk. Low: $0.37
Ytd. Change 17.47%
50 Day Moving Average: $0.72
200 Day Moving Average: $0.68
Shares Outstanding: 37951261


Market Cap: 2.5B
PE Ratio: -
EPS (TTM): 0


Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A